QuidelOrtho Corp Logo

QuidelOrtho Corp

Manufactures in-vitro diagnostic tests for at-home, point-of-care, and clinical lab settings.

QDEL | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
9975 SUMMERS RIDGE ROAD, 92121 SAN DIEGO
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

QuidelOrtho Corporation is a global manufacturer of in-vitro diagnostic (IVD) healthcare products. The company develops and markets a wide range of testing solutions that span the entire healthcare continuum, from at-home and point-of-care tests to large-scale systems for clinical laboratories and hospitals. Its core technologies include immunoassay, molecular diagnostics, clinical chemistry, and immunohematology. QuidelOrtho provides fast and accurate diagnostic insights for various health conditions, specializing in infectious diseases such as COVID-19, flu, strep, and HIV, to support better patient outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all QuidelOrtho Corp filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for QuidelOrtho Corp

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for QuidelOrtho Corp via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Lipocine Inc. Logo
Biopharma developing oral drugs for metabolic & endocrine disorders using delivery technology.
United States of America LPCN
Lipum AB Logo
Develops first-in-class antibody treatments for chronic inflammatory diseases like arthritis.
Sweden LIPUM
Liquidia Corp Logo
Develops inhaled therapies for rare cardiopulmonary diseases using proprietary PRINT® technology.
United States of America LQDA
LISATA THERAPEUTICS, INC. Logo
Oncology firm with a platform for more effective, targeted delivery of anti-cancer drugs.
United States of America LSTA
LIXTE BIOTECHNOLOGY HOLDINGS, INC. Logo
Developing novel PP2A inhibitors to enhance cancer therapies and overcome treatment resistance.
United States of America LIXT
Longeveron Inc. Logo
Develops cell therapies for Alzheimer's, aging frailty, and rare infant heart defects.
United States of America LGVN
Lonza Group AG Logo
A leading CDMO for pharma, biotech & nutrition, providing end-to-end development & manufacturing.
Switzerland LONN
Lyell Immunopharma, Inc. Logo
Develops durable CAR T-cell therapies for solid tumors & blood cancers by reprogramming T-cells.
United States of America LYEL
Lyra Therapeutics, Inc. Logo
Developing localized, long-acting therapies for chronic rhinosinusitis (CRS).
United States of America LYRA
Lytix Biopharma AS Logo
Develops oncolytic peptide immunotherapies that kill cancer and stimulate an anti-tumor response.
Norway LYTIX

Talk to a Data Expert

Have a question? We'll get back to you promptly.